NAABAK 19.6 mg/0.4 ml, eye drops in a single-dose container 36 single-dose containers of 0.4 ml
Active ingredients: Spaglumate sodium
Commercialized according to BDPM
Eye drops36 single-dose containers of 0.4 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NAABAK 19,6 mg/0,4 ml, collyre en récipient unidose
- Pharmaceutical form
- collyre
- Route of administration
- ophtalmique
- Presentation description
- 36 récipient(s) unidose(s) polyéthylène de 0,4 ml
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Jan 2002
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67658048CIP73565151CIP133400935651518Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE N-ACÉTYL ASPARTYL GLUTAMIQUE (SEL DE SODIUM)collyre | 19,6 mg · un récipient unidose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.